We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 30

Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian
  • Shook Hardy & Bacon LLP
  • China, USA
  • August 4 2011

North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province


Medicinova and Zhejiang Medicine announce joint venture in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China


Researchers identify antibiotic-resistant bacteria in pig manure
  • Shook Hardy & Bacon LLP
  • China, USA
  • February 15 2013

A new study has reportedly confirmed the presence of antibiotic-resistant genes (ARGs) in manure samples harvested from swine farms in China, raising


WHO reports first documented human case of avian influenza A
  • Shook Hardy & Bacon LLP
  • China, USA
  • December 20 2013

The World Health Organization (WHO) has reported the first documented case of avian influenza A (H10N8) in a human patient from Jiangxi Province


CFDA seeks comments on revisions to cosmetics regulations
  • Shook Hardy & Bacon LLP
  • China
  • September 26 2013

The China Food and Drug Administration (CFDA) has issued a notice inviting comments on its "Regulations concerning the Hygiene Supervision over


Engineered avian and swine flu hybrids raise concerns about mammal-to-mammal transmission
  • Shook Hardy & Bacon LLP
  • China
  • May 10 2013

Chinese scientists investigating the spread of airborne influenzas have reportedly combined genetic material from avian (H5N1) and swine (H1N1) flu


China’s medical device regulations take effect June 1
  • Shook Hardy & Bacon LLP
  • China
  • May 1 2014

According to news sources, China's amended medical device rules, which increase fines for illegal manufacturing and strengthen government oversight


China to establish food and safety ‘blacklist’
  • Shook Hardy & Bacon LLP
  • USA, China
  • December 20 2013

The Chinese Food and Drug Administration (CFDA) has announced a public consultation on a draft regulation, "Provisions on the Administration of the


Microscopic plastics reportedly detected in table salt
  • Shook Hardy & Bacon LLP
  • China
  • November 13 2015

A study examining table salts sold in China has purportedly found that many brands contain microscopic plastic particles such as polyethylene


Asia’s biomedical R&D spend rises, while U.S. investment declines
  • Shook Hardy & Bacon LLP
  • China, USA
  • January 9 2014

Researchers have found that the U.S. global share of biomedical research expenditures fell from 51 percent in 2007 to 45 percent in 2012, while China